PL2963024T3 - Krystaliczne hydraty chlorku metylotioniny - część 2 - Google Patents

Krystaliczne hydraty chlorku metylotioniny - część 2

Info

Publication number: PL2963024T3
Authority: PL; Poland
Prior art keywords: methylthioninium chloride; chloride hydrates; crystalline methylthioninium; crystalline; hydrates
Prior art date: 2009-09-24

Application number

PL15176967T

Other languages

English (en)

Inventor

Rolf Hilfiker

Timo Rager

Original Assignee

Wista Laboratories Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-09-24

Filing date

2010-09-23

Publication date

2019-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43415329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2963024(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-09-23 Application filed by Wista Laboratories Ltd. filed Critical Wista Laboratories Ltd.

2019-02-28 Publication of PL2963024T3 publication Critical patent/PL2963024T3/pl

Links

LXQCLHQAJVBFGN-UHFFFAOYSA-N 2-methylthionin-1-ium;chloride;hydrate Chemical class O.[Cl-].CC1=CC=CC=CC=C[SH+]1 LXQCLHQAJVBFGN-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
AIDS & HIV (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Steroid Compounds (AREA)

PL15176967T 2009-09-24 2010-09-23 Krystaliczne hydraty chlorku metylotioniny - część 2 PL2963024T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US24539109P	2009-09-24	2009-09-24
PCT/IB2010/002526 WO2011036558A2 (en)	2009-09-24	2010-09-23	Crystalline methylthionium chloride (methylene blue) hydrates
EP10771516.1A EP2480541B1 (en)	2009-09-24	2010-09-23	Crystalline methylthionium chloride (methylene blue) hydrates
EP15176967.6A EP2963024B1 (en)	2009-09-24	2010-09-23	Crystalline methylthioninium chloride hydrates - part 2

Publications (1)

Publication Number	Publication Date
PL2963024T3 true PL2963024T3 (pl)	2019-02-28

Family

ID=43415329

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL20203173.8T PL3792254T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny
PL15176967T PL2963024T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny - część 2
PL10771516T PL2480541T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny (błękitu metylenowego)
PL18170358T PL3378856T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL20203173.8T PL3792254T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PL10771516T PL2480541T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny (błękitu metylenowego)
PL18170358T PL3378856T3 (pl)	2009-09-24	2010-09-23	Krystaliczne hydraty chlorku metylotioniny

Country Status (19)

Country	Link
US (1)	US8765742B2 (pl)
EP (4)	EP3378856B1 (pl)
JP (1)	JP5806217B2 (pl)
KR (3)	KR20170061177A (pl)
CN (2)	CN105061358A (pl)
AU (1)	AU2010299571B2 (pl)
BR (4)	BR112012006638B1 (pl)
CA (4)	CA3004822C (pl)
DK (4)	DK3378856T3 (pl)
ES (4)	ES2847003T3 (pl)
FI (1)	FI3792254T3 (pl)
HR (3)	HRP20181567T2 (pl)
MX (3)	MX355627B (pl)
MY (1)	MY159782A (pl)
PL (4)	PL3792254T3 (pl)
PT (4)	PT3378856T (pl)
SG (1)	SG10201408584UA (pl)
SI (4)	SI3792254T1 (pl)
WO (1)	WO2011036558A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9925282B2 (en)	2009-01-29	2018-03-27	The General Hospital Corporation	Cromolyn derivatives and related methods of imaging and treatment
JP5918136B2 (ja) *	2009-09-24	2016-05-18	ウィスタラボラトリーズリミテッド	プロセス
US10058530B2 (en)	2012-10-25	2018-08-28	The General Hospital Corporation	Combination therapies for the treatment of Alzheimer's disease and related disorders
EP3563849A3 (en) *	2012-10-25	2020-02-12	The General Hospital Corporation	Combination therapies for the treatment of alzheimer's disease and related disorders
US10525005B2 (en)	2013-05-23	2020-01-07	The General Hospital Corporation	Cromolyn compositions and methods thereof
CN110305095A (zh)	2013-10-22	2019-10-08	综合医院公司	色甘酸衍生物以及成像和治疗的相关方法
US10765755B1 (en)	2013-11-20	2020-09-08	University Of South Florida	Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies
JP7073330B2 (ja)	2016-07-25	2022-05-23	ウィスタラボラトリーズリミテッド	ジアミノフェノチアジンの投与及び投与量
JP2019524865A (ja)	2016-08-31	2019-09-05	ザジェネラルホスピタルコーポレイション	神経変性疾患と関連する神経炎症におけるマクロファージ／ミクログリア
GB201614834D0 (en)	2016-09-01	2016-10-19	Wista Lab Ltd	Treatment of dementia
JP7202376B2 (ja)	2017-07-20	2023-01-11	エーゼットセラピーズ，インコーポレイテッド	クロモリンナトリウムおよびイブプロフェンの粉末製剤
AU2019299347A1 (en)	2018-07-02	2021-01-21	Aztherapies, Inc.	Powdered formulations of cromolyn sodium and alpha-lactose
MX2021006869A (es)	2018-12-10	2021-07-02	Massachusetts Gen Hospital	Esteres de cromolin y usos de los mismos.
WO2021207060A1 (en)	2020-04-06	2021-10-14	The General Hospital Corporation	Methods of treatment of coronavirus-induced inflammation conditions
WO2022146914A1 (en)	2020-12-28	2022-07-07	The General Hospital Corporation	Cromolyn derivatives and uses thereof
AU2023279800A1 (en)	2022-05-31	2024-12-19	TauRx Therapeutics Management Ltd	Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds
EP4590306A1 (en)	2022-09-21	2025-07-30	Yin Sze Loh	Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9506197D0 (en)	1995-03-27	1995-05-17	Hoffmann La Roche	Inhibition of tau-tau association.
GB0101049D0 (en)	2001-01-15	2001-02-28	Univ Aberdeen	Materials and methods relating to protein aggregation in neurodegenerative disease
GB0322756D0 (en)	2003-09-29	2003-10-29	Univ Aberdeen	Methods of chemical synthesis
CN101084204B (zh) *	2004-09-23	2012-12-05	卫思道制药有限公司	包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
SI2322517T1 (sl)	2004-09-23	2019-06-28	Wista Laboratories Ltd.	Postopki za kemijsko sintezo in čiščenje diaminofenotiazinijevih spojin, vključno metiltioninijevega klorida (MTC)
SI2004155T1 (en) *	2006-03-29	2018-05-31	Wista Laboratories Ltd.	Inhibitors of protein aggregation
ES2349322T7 (es) *	2006-03-29	2019-10-17	Wista Lab Ltd	Sales de 3,7-diamino-10H-fenotiazina y su utilización
US8227459B2 (en) *	2007-04-03	2012-07-24	Prosetta Antiviral Inc.	Diamino-phenothiazinyl derivatives as antiviral treatments
US7603854B2 (en)	2007-04-10	2009-10-20	Illinois Tool Works Inc.	Pneumatically self-regulating valve

2010
- 2010-09-23 MX MX2015008552A patent/MX355627B/es unknown
- 2010-09-23 CN CN201510501874.XA patent/CN105061358A/zh active Pending
- 2010-09-23 MX MX2018004983A patent/MX381636B/es unknown
- 2010-09-23 EP EP18170358.8A patent/EP3378856B1/en active Active
- 2010-09-23 HR HRP20181567TT patent/HRP20181567T2/hr unknown
- 2010-09-23 PL PL20203173.8T patent/PL3792254T3/pl unknown
- 2010-09-23 PT PT181703588T patent/PT3378856T/pt unknown
- 2010-09-23 SG SG10201408584UA patent/SG10201408584UA/en unknown
- 2010-09-23 DK DK18170358.8T patent/DK3378856T3/da active
- 2010-09-23 PT PT15176967T patent/PT2963024T/pt unknown
- 2010-09-23 DK DK15176967.6T patent/DK2963024T3/en active
- 2010-09-23 WO PCT/IB2010/002526 patent/WO2011036558A2/en not_active Ceased
- 2010-09-23 PT PT202031738T patent/PT3792254T/pt unknown
- 2010-09-23 DK DK10771516.1T patent/DK2480541T3/en active
- 2010-09-23 SI SI201032134T patent/SI3792254T1/sl unknown
- 2010-09-23 PL PL15176967T patent/PL2963024T3/pl unknown
- 2010-09-23 PL PL10771516T patent/PL2480541T3/pl unknown
- 2010-09-23 ES ES18170358T patent/ES2847003T3/es active Active
- 2010-09-23 EP EP15176967.6A patent/EP2963024B1/en active Active
- 2010-09-23 EP EP10771516.1A patent/EP2480541B1/en active Active
- 2010-09-23 CN CN201080053178.2A patent/CN102666511B/zh active Active
- 2010-09-23 PT PT107715161T patent/PT2480541E/pt unknown
- 2010-09-23 US US13/497,686 patent/US8765742B2/en active Active
- 2010-09-23 JP JP2012530357A patent/JP5806217B2/ja active Active
- 2010-09-23 MY MYPI2012001322A patent/MY159782A/en unknown
- 2010-09-23 CA CA3004822A patent/CA3004822C/en active Active
- 2010-09-23 BR BR112012006638-2A patent/BR112012006638B1/pt active IP Right Grant
- 2010-09-23 AU AU2010299571A patent/AU2010299571B2/en not_active Ceased
- 2010-09-23 KR KR1020177013764A patent/KR20170061177A/ko not_active Ceased
- 2010-09-23 SI SI201031765T patent/SI2963024T1/sl unknown
- 2010-09-23 SI SI201032051T patent/SI3378856T1/sl unknown
- 2010-09-23 DK DK20203173.8T patent/DK3792254T3/da active
- 2010-09-23 BR BR122019022612A patent/BR122019022612B8/pt active IP Right Grant
- 2010-09-23 EP EP20203173.8A patent/EP3792254B1/en active Active
- 2010-09-23 BR BR122019022628A patent/BR122019022628B8/pt active IP Right Grant
- 2010-09-23 CA CA3077911A patent/CA3077911C/en active Active
- 2010-09-23 SI SI201031101T patent/SI2480541T1/sl unknown
- 2010-09-23 CA CA2773305A patent/CA2773305C/en active Active
- 2010-09-23 ES ES20203173T patent/ES2960761T3/es active Active
- 2010-09-23 ES ES10771516.1T patent/ES2557318T3/es active Active
- 2010-09-23 FI FIEP20203173.8T patent/FI3792254T3/fi active
- 2010-09-23 HR HRP20231201TT patent/HRP20231201T1/hr unknown
- 2010-09-23 CA CA3141737A patent/CA3141737C/en active Active
- 2010-09-23 ES ES15176967.6T patent/ES2689029T3/es active Active
- 2010-09-23 BR BR122019022631A patent/BR122019022631B8/pt active IP Right Grant
- 2010-09-23 KR KR1020127009853A patent/KR20120099409A/ko not_active Ceased
- 2010-09-23 KR KR1020187022958A patent/KR20180094126A/ko not_active Ceased
- 2010-09-23 MX MX2012003083A patent/MX2012003083A/es active IP Right Grant
- 2010-09-23 PL PL18170358T patent/PL3378856T3/pl unknown
2021
- 2021-01-19 HR HRP20210086TT patent/HRP20210086T1/hr unknown

Also Published As

Publication number	Publication date
EP3378856B1 (en)	2020-12-02
BR122019022631B1 (pt)	2021-03-16
EP2963024A2 (en)	2016-01-06
MY159782A (en)	2017-01-31
SG10201408584UA (en)	2015-02-27
BR122019022628B8 (pt)	2021-07-27
AU2010299571A1 (en)	2012-04-12
CA3077911C (en)	2022-03-01
US8765742B2 (en)	2014-07-01
DK3792254T3 (da)	2023-09-25
CA3004822C (en)	2020-07-21
PT3792254T (pt)	2023-10-19
AU2010299571B2 (en)	2014-07-31
PT2480541E (pt)	2016-01-26
SI2963024T1 (sl)	2018-10-30
SI2480541T1 (sl)	2016-02-29
CN102666511A (zh)	2012-09-12
FI3792254T3 (fi)	2023-09-22
HRP20231201T1 (hr)	2024-01-19
CA3141737A1 (en)	2011-03-31
ES2689029T3 (es)	2018-11-08
EP2480541A2 (en)	2012-08-01
WO2011036558A9 (en)	2011-08-04
KR20170061177A (ko)	2017-06-02
ES2557318T3 (es)	2016-01-25
EP2963024B1 (en)	2018-07-18
CN102666511B (zh)	2015-09-16
WO2011036558A3 (en)	2011-11-24
JP2013505925A (ja)	2013-02-21
SI3378856T1 (sl)	2021-03-31
US20120238556A1 (en)	2012-09-20
DK3378856T3 (da)	2020-12-21
DK2480541T3 (en)	2016-02-01
MX381636B (es)	2025-03-13
PT2963024T (pt)	2018-10-16
CA3141737C (en)	2023-10-03
PL3378856T3 (pl)	2021-05-31
BR122019022631B8 (pt)	2021-07-27
HRP20181567T2 (hr)	2022-09-30
MX355627B (es)	2018-04-25
PL2480541T3 (pl)	2016-03-31
EP2480541B1 (en)	2015-11-04
ES2847003T3 (es)	2021-07-30
EP2963024A3 (en)	2016-02-17
WO2011036558A2 (en)	2011-03-31
PT3378856T (pt)	2021-02-02
CA2773305C (en)	2018-07-03
CA3004822A1 (en)	2011-03-31
BR112012006638A2 (pt)	2016-05-03
KR20180094126A (ko)	2018-08-22
HK1167653A1 (zh)	2012-12-07
HRP20210086T1 (hr)	2021-03-05
MX2012003083A (es)	2012-04-30
HK1213897A1 (en)	2016-07-15
CA2773305A1 (en)	2011-03-31
EP3378856A2 (en)	2018-09-26
EP3792254A1 (en)	2021-03-17
KR20120099409A (ko)	2012-09-10
EP3378856A3 (en)	2018-11-07
ES2960761T3 (es)	2024-03-06
JP5806217B2 (ja)	2015-11-10
HRP20181567T1 (hr)	2018-11-30
PL3792254T3 (pl)	2024-02-12
SI3792254T1 (sl)	2023-11-30
DK2963024T3 (en)	2018-10-08
BR122019022628B1 (pt)	2021-03-16
BR112012006638B1 (pt)	2020-05-26
CA3077911A1 (en)	2011-03-31
CN105061358A (zh)	2015-11-18
EP3792254B1 (en)	2023-07-26
BR122019022612B8 (pt)	2021-07-27
BR122019022612B1 (pt)	2021-03-09

Publication	Publication Date	Title
HRP20181567T1 (hr)	2018-11-30	Kristalni metiltioninium klorid hidrati - drugi dio
HUS1800015I1 (hu)	2018-05-28	Kristályok
ZA201108962B (en)	2012-08-29	Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
ZA201105462B (en)	2015-01-28	Crystalline insulin-conjugates
GB0819182D0 (en)	2008-11-26	Crystalline forms
GB0908772D0 (en)	2009-07-01	New salts 756
GB0913345D0 (en)	2009-09-16	New combination 802
EP2448934A4 (en)	2012-12-05	DERIVATIVES OF 2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN
GB0900404D0 (en)	2009-02-11	New compounds 4
GB0912946D0 (en)	2009-09-02	New compounds 5
GB0900870D0 (en)	2009-03-04	Loo 2
PL2173710T3 (pl)	2016-02-29	Nowa postać krystaliczna
EP2513131A4 (en)	2013-10-16	NOVEL 3'-DEOXY-3'-METHYLIDENE-L-NUCLEOSIDES
HU0800755D0 (en)	2009-03-30	Novel crystalline forms
GB0703998D0 (en)	2007-04-11	Novel salt
GB0913344D0 (en)	2009-09-16	Compounds 762
GB0918322D0 (en)	2009-12-02	Compounds 814
GB0916350D0 (en)	2009-10-28	Flexi-bend 2000
GB0901941D0 (en)	2009-03-11	1007
GB0902804D0 (en)	2009-04-08	Fusebox 2
GB0903160D0 (en)	2009-04-08	Fusebox 4
GB0921324D0 (en)	2010-01-20	Guttergrow 2
GB0900400D0 (en)	2009-02-11	New compounds 3
GB0900392D0 (en)	2009-02-11	New compounds 2
GB0912947D0 (en)	2009-09-02	New compounds 6